EE215 Pharmacoeconomic Analysis of Adjuvant Nivolumab for Patients With Resected Esophageal or Gastroesophageal Junction Cancer in Switzerland
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.464
https://www.valueinhealthjournal.com/article/S1098-3015(22)02668-7/fulltext
Title :
EE215 Pharmacoeconomic Analysis of Adjuvant Nivolumab for Patients With Resected Esophageal or Gastroesophageal Junction Cancer in Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02668-7&doi=10.1016/j.jval.2022.09.464
First page :
Section Title :
Open access? :
No
Section Order :
12273